Consolidated Statement of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Capital in Excess of Par Value [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2020	$ 6,232.7	$ 193.7	$ 4,264.4	$ 2,371.7	$ (643.6)	$ 46.5
Beginning balance (in shares) at Dec. 31, 2020		193.7
Net earnings	955.0			906.8		48.2
Net purchase of subsidiary shares from noncontrolling interests	(6.0)					(6.0)
Dividends paid to noncontrolling interests	(38.3)					(38.3)
Net change in pension asset/liability, net of taxes	19.0				19.0
Foreign currency translation	(121.0)				(122.3)	1.3
Change in fair value of derivative instruments, net of taxes	20.8				20.8
Compensation expense related to stock option plan grants	17.5		17.5
Common stock issued in: purchase transactions	251.3	$ 1.7	249.6
Common stock issued in: purchase transactions (in shares)		1.7
Stock option plans	67.6	$ 1.4	66.2
Stock option plans (in shares)		1.4
Employee stock purchase plan	41.2	$ 0.4	40.8
Employee stock purchase plan (in shares)		0.4
Shares issued to benefit plans	71.4	$ 0.6	70.8
Shares issued to benefit plans (in shares)		0.6
Deferred compensation and restricted stock	6.9	$ 0.4	6.5
Deferred compensation and restricted (in shares)		0.4
Stock issuance from public offering	1,437.9	$ 10.3	1,427.6
Stock issuance from public offering (in shares)		10.3
Other compensation expense	0.3		0.3
Cash dividends declared on common stock	(396.2)			(396.2)
Ending balance at Dec. 31, 2021	8,560.1	$ 208.5	6,143.7	2,882.3	(726.1)	51.7
Ending balance (in shares) at Dec. 31, 2021		208.5
Net earnings	1,116.0			1,114.2		1.8
Net purchase of subsidiary shares from noncontrolling interests	(3.2)					(3.2)
Dividends paid to noncontrolling interests	(3.5)					(3.5)
Net change in pension asset/liability, net of taxes	(12.3)				(12.3)
Foreign currency translation	(512.0)				(511.8)	(0.2)
Change in fair value of derivative instruments, net of taxes	109.8				109.8
Compensation expense related to stock option plan grants	27.9		27.9
Common stock issued in: purchase transactions	165.5	$ 0.9	164.6
Common stock issued in: purchase transactions (in shares)		0.9
Stock option plans	$ 76.1	$ 1.4	74.7
Stock option plans (in shares)	1.4	1.4
Employee stock purchase plan	$ 47.6	$ 0.3	47.3
Employee stock purchase plan (in shares)		0.3
Deferred compensation and restricted stock	(21.9)	$ 0.3	(22.2)
Deferred compensation and restricted (in shares)		0.3
Cash dividends declared on common stock	(434.3)			(434.3)
Ending balance at Dec. 31, 2022	$ 9,190.2	$ 211.9	6,509.9	3,562.2	(1,140.4)	46.6
Ending balance (in shares) at Dec. 31, 2022	211.9	211.9
Net earnings	$ 966.0			969.5		(3.5)
Net purchase of subsidiary shares from noncontrolling interests	(3.1)					(3.1)
Dividends paid to noncontrolling interests	(1.0)					(1.0)
Net change in pension asset/liability, net of taxes	12.3				12.3
Foreign currency translation	258.8				257.8	1.0
Change in fair value of derivative instruments, net of taxes	78.2				78.2
Compensation expense related to stock option plan grants	33.5		33.5
Common stock issued in: purchase transactions	525.8	$ 2.5	523.3
Common stock issued in: purchase transactions (in shares)		2.5
Stock option plans	$ 65.2	$ 1.2	64.0
Stock option plans (in shares)	1.3	1.2
Employee stock purchase plan	$ 55.0	$ 0.3	54.7
Employee stock purchase plan (in shares)		0.3
Shares issued to benefit plans	84.6	$ 0.4	84.2
Shares issued to benefit plans (in shares)		0.4
Deferred compensation and restricted stock	28.6	$ 0.4	28.2
Deferred compensation and restricted (in shares)		0.4
Cash dividends declared on common stock	(478.8)			(478.8)
Ending balance at Dec. 31, 2023	$ 10,815.3	$ 216.7	$ 7,297.8	$ 4,052.9	$ (792.1)	$ 40.0
Ending balance (in shares) at Dec. 31, 2023	216.7	216.7